Trends in High-grade Cervical Lesions and Cervical Cancer Screening in Five States, 2008-2015.

Abstract

We describe changes in rates of cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ (CIN2+) during a period of human papillomavirus (HPV) vaccine uptake and changing cervical cancer screening recommendations.